Yujiro Ueda Selected Research

Oxaliplatin (Eloxatin)

5/2021	A multicenter propensity score analysis of FOLFIRINOX vs gemcitabine plus nab-paclitaxel administered to patients with metastatic pancreatic cancer: results from the NAPOLEON study.
1/2021	Gemcitabine Plus Nab-Paclitaxel Versus FOLFIRINOX in Locally Advanced, Unresectable Pancreatic Cancer: A Multicenter Observational Study (NAPOLEON Study).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yujiro Ueda Research Topics

Disease

6	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 01/2021
2	Neoplasms (Cancer) 01/2022 - 10/2017
2	Prostatic Neoplasms (Prostate Cancer) 01/2017 - 08/2015
1	Histiocytic Sarcoma 10/2017
1	Disease Progression 08/2015

Drug/Important Bio-Agent (IBA)

6	Gemcitabine FDA Link 01/2022 - 01/2021
5	130-nm albumin-bound paclitaxelIBA 01/2022 - 01/2021
5	folfirinoxIBA 01/2022 - 01/2021
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 05/2021 - 01/2021
2	Irinotecan (Camptosar)FDA LinkGeneric 05/2021 - 01/2021
2	Leucovorin (Folinic Acid)FDA Link 05/2021 - 01/2021
2	Fluorouracil (Carac)FDA LinkGeneric 05/2021 - 01/2021
2	Abiraterone AcetateIBA 01/2017 - 08/2015
1	C-Reactive ProteinIBA 01/2022
1	Albumin-Bound Paclitaxel FDA Link 07/2021
1	Prostate-Specific Antigen (Semenogelase)IBA 01/2017
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2017
1	Docetaxel (Taxotere)FDA Link 08/2015

Therapy/Procedure

4	Drug Therapy (Chemotherapy) 07/2021 - 01/2017
2	Castration 01/2017 - 08/2015
1	Therapeutics 05/2021
1	Nephrectomy 10/2017
1	Induction Chemotherapy 10/2017